Back to MORGAN STANLEY MORGAN STANLEY

NTLANTLA
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in INTELLIA THERAPEUTICS INC

MORGAN STANLEY holds 1.7M shares of NTLA (INTELLIA THERAPEUTICS INC), worth $29.3M as of 2026-Q2. The position was decreased (-16.8% shares). NTLA represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$29.3M

Current Shares

1.7M

Total Value Change

-$23.6M

Total Shares Change

-844,129

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.7M
-16.8%
$29.3M0.0%$16.92
0
2026-Q1
Decreased
2.1M
-10.6%
$26.7M0.0%$13.60
0
2025-Q4
Decreased
2.3M
-61.4%
$20.9M0.0%$9.06
0
2025-Q3
Increased
6M
+46.3%
$104M0.0%$16.92
41
2025-Q2
Increased
4.1M
+8.3%
$38.6M0.0%$9.56
32
2025-Q1
Decreased
3.8M
-0.3%
$27M0.0%$8.07
0
2024-Q4
Increased
3.8M
+48.1%
$44.5M0.0%$11.41
40
2024-Q3
Increased
2.6M
+10.2%
$52.9M0.0%$21.00
32

Other major holders of NTLA: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used